Pharmacological modulation of Sonic Hedgehog signaling pathways in Angiogenesis : A mechanistic perspective
Copyright © 2023 Elsevier Inc. All rights reserved..
The Sonic hedgehog (SHh) signaling pathway is an imperative operating network that helps in regulates the critical events during the development processes like multicellular embryo growth and patterning. Disruptions in SHh pathway regulation can have severe consequences, including congenital disabilities, stem cell renewal, tissue regeneration, and cancer/tumor growth. Activation of the SHh signal occurs when SHh binds to the receptor complex of Patch (Ptc)-mediated Smoothened (Smo) (Ptc-smo), initiating downstream signaling. This review explores how pharmacological modulation of the SHh pathway affects angiogenesis through canonical and non-canonical pathways. The canonical pathway for angiogenesis involves the activation of angiogenic cytokines such as fibroblast growth factor (FGF), vascular endothelial growth factor (VEGF), placental growth factor (PGF), hepatocyte growth factor (HGF), platelet-derived growth factor (PDGF), stromal cell-derived factor 1α, transforming growth factor-β1 (TGF-β1), and angiopoietins (Ang-1 and Ang-2), which facilitate the process of angiogenesis. The Non-canonical pathway includes indirect activation of certain pathways like iNOS/Netrin-1/PKC, RhoA/Rock, ERK/MAPK, PI3K/Akt, Wnt/β-catenin, Notch signaling pathway, and so on. This review will provide a better grasp of the mechanistic approach of SHh in mediating angiogenesis, which can aid in the suppression of certain cancer and tumor growths.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:504 |
---|---|
Enthalten in: |
Developmental biology - 504(2023) vom: 01. Dez., Seite 58-74 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mannan, Ashi [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 06.11.2023 Date Revised 07.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ydbio.2023.09.009 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362356319 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM362356319 | ||
003 | DE-627 | ||
005 | 20231226091052.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ydbio.2023.09.009 |2 doi | |
028 | 5 | 2 | |a pubmed24n1207.xml |
035 | |a (DE-627)NLM362356319 | ||
035 | |a (NLM)37739118 | ||
035 | |a (PII)S0012-1606(23)00163-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mannan, Ashi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pharmacological modulation of Sonic Hedgehog signaling pathways in Angiogenesis |b A mechanistic perspective |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.11.2023 | ||
500 | |a Date Revised 07.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
520 | |a The Sonic hedgehog (SHh) signaling pathway is an imperative operating network that helps in regulates the critical events during the development processes like multicellular embryo growth and patterning. Disruptions in SHh pathway regulation can have severe consequences, including congenital disabilities, stem cell renewal, tissue regeneration, and cancer/tumor growth. Activation of the SHh signal occurs when SHh binds to the receptor complex of Patch (Ptc)-mediated Smoothened (Smo) (Ptc-smo), initiating downstream signaling. This review explores how pharmacological modulation of the SHh pathway affects angiogenesis through canonical and non-canonical pathways. The canonical pathway for angiogenesis involves the activation of angiogenic cytokines such as fibroblast growth factor (FGF), vascular endothelial growth factor (VEGF), placental growth factor (PGF), hepatocyte growth factor (HGF), platelet-derived growth factor (PDGF), stromal cell-derived factor 1α, transforming growth factor-β1 (TGF-β1), and angiopoietins (Ang-1 and Ang-2), which facilitate the process of angiogenesis. The Non-canonical pathway includes indirect activation of certain pathways like iNOS/Netrin-1/PKC, RhoA/Rock, ERK/MAPK, PI3K/Akt, Wnt/β-catenin, Notch signaling pathway, and so on. This review will provide a better grasp of the mechanistic approach of SHh in mediating angiogenesis, which can aid in the suppression of certain cancer and tumor growths | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Angiogenesis | |
650 | 4 | |a Cancer/tumor growth | |
650 | 4 | |a Canonical pathway | |
650 | 4 | |a Non-canonical pathway | |
650 | 4 | |a Sonic hedgehog | |
650 | 4 | |a VEGF | |
650 | 7 | |a Hedgehog Proteins |2 NLM | |
650 | 7 | |a Vascular Endothelial Growth Factor A |2 NLM | |
650 | 7 | |a Phosphatidylinositol 3-Kinases |2 NLM | |
650 | 7 | |a EC 2.7.1.- |2 NLM | |
650 | 7 | |a Placenta Growth Factor |2 NLM | |
650 | 7 | |a 144589-93-5 |2 NLM | |
700 | 1 | |a Dhiamn, Sonia |e verfasserin |4 aut | |
700 | 1 | |a Garg, Nikhil |e verfasserin |4 aut | |
700 | 1 | |a Singh, Thakur Gurjeet |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Developmental biology |d 1960 |g 504(2023) vom: 01. Dez., Seite 58-74 |w (DE-627)NLM000003484 |x 1095-564X |7 nnns |
773 | 1 | 8 | |g volume:504 |g year:2023 |g day:01 |g month:12 |g pages:58-74 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ydbio.2023.09.009 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 504 |j 2023 |b 01 |c 12 |h 58-74 |